Blog

During the last Open Innovation Summit held at the main headquarters of Compensar, the District Institute of Science, Biotechnology and Innovation IDCBIS was present with a stand that allowed attendees to learn about the different services, products and research results that have been obtained in the last year, During this time, IDCBIS evolved from being the District Hemocenter to an institute for research, innovation and knowledge management in biomedical sciences, which provides services and human biological inputs for the benefit of individual and collective health to improve the quality of life and welfare of the community in Colombia.

The District Institute of Science, Biotechnology and Innovation in Health - IDCBIS joined the international day of organ and tissue donation. Below is the message sent to the public by the director of IDCBIS, Dr. Bernardo Camacho.

Rachel Reynolds, Senior Policy Manager at the UK Research Council and Daniela Hensen, PhD Strategy and Policy Officer at the Biotechnology and Biological Sciences Research Council visited IDCBIS to learn about the Institute's research progress and results.

This visit was made possible thanks to the efforts of Colciencias, in charge of showing the panorama of the country's National Science and Technology System and strengthening bilateral relations in this area through the exchange of best practices. It is hoped that this exchange will lead to a stronger relationship between the RCUKs and their Colombian counterparts.

The RCUK is a non-departmental public body that coordinates science policy in the UK. It consists of seven Research Councils that are responsible for funding and coordinating academic research for the arts, humanities, science and engineering.

On August 15 in Goettingen, Germany, the District Institute for Science, Biotechnology and Innovation in Health (IDCBIS) and the German Primate Center (DPZ), headed by Dr. Jens Grube, signed a scientific cooperation agreement that will last until April 2019.

Gustavo Salguero MD. PhD., Research Leader of the Cell Therapy Unit, was delegated by IDCBIS to sign the agreement and Dr. Jens Gruber and Dr. Manfred Eberle attended on behalf of DPZ. The event was attended by Ambassador Maria Lorena Gutierrez and the Embassy staff.

Colciencias was the mediating entity for the scientific cooperation process, through the annual call for binational mobility of researchers and the German Federal Ministry of Education and Research (BMBF).

This agreement was developed jointly between DPZ and IDCBIS, with the objective of joining efforts for the generation and transfer of knowledge and technology, as well as to research and implement new therapeutic strategies that combine stem cells and genetic modification or gene therapy technologies.

"The institutions expressed interest in cooperating in knowledge sharing, personnel exchange, and joint research projects that ultimately lead to publishable data and advances in technological development. According to the signed document, the parties agree to transfer knowledge in terms of training personnel to establish analysis techniques and workflows involving next-generation cell biochemistry or deep sequencing (NGS), and genetic manipulation and analysis of NGS data. IDCBIS will provide knowledge on the biology of human stem cells and their specific applications as therapeutic tools for immunotherapy and regeneration," said Colciencias Administrative Department of Science, Technology and Innovation.

This first agreement is part of the IDCBIS projection at national and international level as a center of excellence in biomedical sciences research and biotechnology in health.

More information at: